Takeda Pharmaceutical
TAK
#444
Rank
HK$450.14 B
Marketcap
HK$140.96
Share price
-0.25%
Change (1 day)
19.27%
Change (1 year)

Takeda Pharmaceutical (TAK) - P/B ratio

P/B ratio as of August 2026 : 1.23

According to Takeda Pharmaceutical's latest financial reports the company has a price-to-book ratio of 1.93633.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Takeda Pharmaceutical - P/B ratio (from 2008 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-311.0619.36%
2024-12-310.8911-5.39%
2023-12-310.9418-8.33%
2022-12-311.0311.47%
2021-12-310.9217-27.15%
2020-12-311.27-8.56%
2019-12-311.38-2.36%
2018-12-311.42-39.4%
2017-12-312.3425.64%
2016-12-311.86-15.57%
2015-12-312.2043.79%
2014-12-311.53-1.26%
2013-12-311.558.32%
2012-12-311.435.58%
2011-12-311.36-9.3%
2010-12-311.504.62%
2009-12-311.43-33.87%
2008-12-312.16

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.96 547.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.51 511.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.76 43.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
25.4 1,970.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.27 3.24%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
7.97 548.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.41 259.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
16.9 1,277.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
2.49 102.88%๐Ÿ‡ฎ๐Ÿ‡ณ India